SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-13-051746
Filing Date
2013-06-27
Accepted
2013-06-27 09:20:18
Documents
4
Period of Report
2013-06-19
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a13-15552_18ka.htm 8-K/A 40887
2 EX-99.3 a13-15552_1ex99d3.htm EX-99.3 621563
3 EX-99.4 a13-15552_1ex99d4.htm EX-99.4 464279
4 EX-99.5 a13-15552_1ex99d5.htm EX-99.5 342234
  Complete submission text file 0001104659-13-051746.txt   1470119
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-31812 | Film No.: 13936073
SIC: 2836 Biological Products, (No Diagnostic Substances)